GALVmed’s commercial development activities are underwritten by the willingness of small-scale livestock producers (SSPs) to pay the market price for effective livestock health products (particularly vaccines) and services. It is this commercial principle that will allow GALVmed to achieve its ultimate vision of vaccines and other essential animal health products being widely available to SSPs around the globe.

The goals of GALVmed’s commercial development work are:

• To establish large-scale distribution systems providing access to animal health products and services for SSPs in Sub-Saharan Africa and South Asia which…
• …are profitable and therefore sustainable post-funding and which…
• …show the way for the Animal Health industry more generally to engage with the small-scale market…
• …resulting in significant positive economic impact.

Currently, commercial development activities are focused on establishing large-scale distribution networks and providing a broad portfolio of animal health products to tackle economically important diseases for SSPs.

GALVmed’s commercial development function will continue to test and demonstrate the underlying business case for the establishment of distribution networks for the smallholder segment. With the animal health industry fully engaged in this way, hundreds of millions of SSPs around the world can have access to affordable and vitally needed agricultural inputs – livestock vaccines and medicines.